193 filings
Page 4 of 10
8-K
9nl8sv dwiin5194
3 Apr 20
Departure of Directors or Certain Officers
4:30pm
8-K
3w45lqgbnbvo11k 2p9
20 Mar 20
Departure of Directors or Certain Officers
4:30pm
8-K
huljukex10y3pw7alo
16 Mar 20
Departure of Directors or Certain Officers
4:30pm
8-K
j0w4xug
6 Feb 20
Departure of Directors or Certain Officers
9:22am
8-K
64472t0e5
20 Dec 19
Departure of Directors or Certain Officers
4:15pm
8-K
4l54qjnuj v891j8ty
10 Oct 19
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
ls3em57q
16 Sep 19
NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors
4:30pm
8-K
268mdrpu 6z8w7ccsrdm
13 Aug 19
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
m8iusq8i wm50qjd
9 Aug 19
NovaBay Pharmaceuticals Announces Pricing of $4.2 Million Registered Direct Offering
9:02am
8-K
32tglcwcy
7 Aug 19
NovaBay Pharmaceuticals Reports 2019 Second Quarter Financial Results
8:00am
8-K
19et1fejenx
29 Jul 19
NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million
8:30am
8-K
exp 5jkuem6
25 Jul 19
Departure of Directors or Certain Officers
4:30pm
8-K
zdi6 x13kb
15 Jul 19
NovaBay Pharmaceuticals Issues Letter to Stockholders
8:30am
8-K
utopui7g
1 Jul 19
Other Events
8:32am
8-K
hhbqd8p
26 Jun 19
Entry into a Material Definitive Agreement
4:31pm
8-K
3031cop
19 Jun 19
Entry into a Material Definitive Agreement
8:30am
8-K
4ca5lz1sxrp5nta
17 Jun 19
NovaBay Pharmaceuticals Appoints Justin Hall President and CEO, and Jason Raleigh CFO
8:31am
8-K
rkt9r60
3 Jun 19
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
jlokpaydc3
21 May 19
NovaBay Pharmaceuticals Receives NYSE American Communication
4:50pm
8-K
nqbhef3qlail c1z
13 May 19
NovaBay Pharmaceuticals Reports First Quarter 2019 Financial Results
4:30pm